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considerations, togetherwith an improved
understanding of the signals regulating
Fringe activity, should provide a more
comprehensive picture into how Notch
signaling regulates peripheral lymphocyte
development and differentiation.
In sum, the cellular and molecular
events that regulate the follicular and MZ
B cell-fate choice remain poorly under-
stood. Whether all immature B cells are
equally likely to gain access to the requi-
site signals, whether specific subsets of
maturing B cells receive such signals,
and how such signals are integrated to
induce the MZ B cell-fate are open ques-
tions. The data provided by Tan et al.
provide an important leap forward in our
understanding of these issues, especially
in the context of the role of Notch activity
in this process.
REFERENCES
Hozumi, K., Negishi, N., Suzuki, D., Abe, N., Soto-
maru, Y., Tamaoki, N., Mailhos, C., Ish-Horowicz,
D., Habu, S., and Owen, M.J. (2004). Nat. Immunol.
5, 638–644.
Lu, T.T., and Cyster, J.G. (2002). Science 297, 409–
412.
Maillard, I., Fang, T., and Pear, W.S. (2005). Annu.
Rev. Immunol. 23, 945–974.
Martin, F., and Kearney, J.F. (2000). Immunity 12,
39–49.
Pillai, S., Cariappa, A., and Moran, S.T. (2005).
Annu. Rev. Immunol. 23, 161–196.
Saito, T., Chiba, S., Ichikawa, M., Kunisato, A.,
Asai, T., Shimizu, K., Yamaguchi, T., Yamamoto,
G., Seo, S., Kumano, K., et al. (2003). Immunity
18, 675–685.
Stanley, P. (2007). Curr. Opin. Struct. Biol. 17, 530–
535.
Tan, J.B., Xu, K., Cretegny, K., Visan, I., Yuan, J.S.,
Egan, S.E., and Guidos, S.J. (2009). Immunity 30,
this issue, 254–263.
Thomas, M., Calamito, M., Srivastava, B., Maillard,
I., Pear, W.S., and Allman, D. (2007). Blood 109,
3342–3350.
Wen, L., Brill-Dashoff, J., Shinton, S.A., Asano, M.,
Hardy, R.R., and Hayakawa, K. (2005). Immunity
23, 297–308.
Immunity
PreviewsThe Antigen Expressway:
Follicular Conduits Carry Antigen to B Cells
Naomi E. Harwood1 and Facundo D. Batista1,*
1Lymphocyte Interaction Laboratory, Cancer Research UK London Research Institute, Lincoln’s Inn Fields Laboratories,
44 Lincoln’s Inn Fields, London WC2A 3PX, UK
*Correspondence: facundo.batista@cancer.org.uk
DOI 10.1016/j.immuni.2009.01.004
In this issue of Immunity, Roozendaal et al. (2009) visualize a conduit system within the lymph node follicle
that allows transport of small antigens and chemokines from the subcapsular sinus to follicular B cells.The intriguing question of how antigen is
delivered to follicular B cells to initiate
humoral immune responses has occupied
immunologists formore than four decades
(Nossal et al., 1968). In spite of this,
the mechanism by which B cells first
encounter antigen to initiate activation
in vivo remains somewhat enigmatic. It is
well established that these encounters
are localized to specialized secondary
lymphoid tissues, such as the lymph
nodes (LNs), as a means of increasing
the likelihood that B cells will encounter
cognate antigen. However, although the
LN is continually supplied with lymphatic
fluid through the afferent vessel, tight
packing of cells at the subcapsular sinus
(SCS)prevents the freediffusionof antigen
into the LN interior, raising the question of
how antigen can gain access to B cells
contained within follicles. Given the phys-iological importance of antigen-mediated
activation of B cells, considerable effort
has been invested in applying innovative
technologies to this complex biological
puzzle, and indeed, very recently these
have yielded a number of exciting solu-
tions (Batista and Harwood, 2009).
In this issue, Roozendaal et al. (2009)
substantially extend the understanding
of the B cell activation process in vivo by
revealing a mechanism by which follicular
B cells encounter antigen (Figure 1). This
current study builds on the foundation
laid by a group of four studies that were
published in 2007. The first of these
demonstrated that within minutes of injec-
tion, small soluble antigen diffuses directly
through the SCS, leading to activation of
follicular B cells according to their prox-
imity to the SCS (Pape et al., 2007). This
diffusion was suggested to occur throughImmunity 30pores in the SCS that were detected in
earlier electron microscopy investigations.
Such a mechanism does not, however,
provide a route for larger antigens to gain
access to follicular B cells, indicating that
the strategy used for initiatingB cell activa-
tion is tailored to the characteristics of the
antigen itself. Indeed, three subsequent
studies have revealed an alternative cell-
mediated mechanism by which follicular
Bcellsencounter largerantigens (Carrasco
and Batista, 2007; Junt et al., 2007; Phan
et al., 2007). These investigations moni-
tored the spatiotemporal dynamics of
follicular B cells within the LN relative to
particulate antigens, immune complexes,
or viruses with multiphoton microscopy.
Each of these larger antigens was rapidly
localized at the SCS, where macrophages
can present the antigen and mediate the
retention of specific B cells. Subsequently,, February 20, 2009 ª2009 Elsevier Inc. 177
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PreviewsFigure 1. Antigen Presentation to Follicular B Cells in the LN
The LN is supplied with lymphatic fluid containing antigens and chemokines (shown in red and green, respectively) through the afferent lymph vessel. On arrival,
CD169+ macrophages lining the SCS prevent free diffusion of lymphatic fluid to the LN interior. Larger antigens (diamonds) are accumulated by SCS macro-
phages and can be directly presented to antigen-specific B cells (the B cell receptor is shown in red) in the follicle. In addition, larger antigens can be transported
by nonspecific B cells to FDCs in a complement-dependent manner. This transport may allow FDCs to mediate antigen presentation to specific naive B cells. In
contrast, smaller (less than 70 kDa) antigens and chemokines (circles) can access antigen-specific B cells in the follicle either by direct diffusion from pores in the
SCS or via the follicular conduit system. These follicular conduits extend from the SCS and are comprised of bundles of collagen fibers ensheathed by fibror-
eticular cells (FRCs). Because the FRC network is not completely continuous, follicular B cells can extend protrusions through tiny gaps to sample the transported
components of lymphatic fluid.B cells that had acquired antigen polarized
toward the boundary between B and T cell
zones to recruit cognate CD4+ T cell help
for maximal activation. Interestingly, in
the absence of specific B cells, noncog-
nate B cells were found to be capable of
mediating complement-dependent trans-
port of antigen from the SCS to follicular
dendritic cells (FDCs). Together, these
four studies highlight the SCS as a critical
site for B cell encounter with antigen, and
thus the region plays a key role in the initia-
tion of humoral immunity.
In the present study, Roozendaal et al.
(2009) use an innovative combination of
classic immunological andhigh-resolution
microscopy techniques to visualize the
distribution of various antigens and the
corresponding behaviors induced in follic-
ular B cells within peripheral LNs. Initially,
they observed that immune complexes
covering a range of sizes were accumu-
lated on the surface of FDCs at different
rates. In agreement with previous studies,
larger antigens, such as phycoerytherin
(PE), accumulated on FDCs approxi-
mately 8 hr after administration (Carrasco178 Immunity 30, February 20, 2009 ª2009and Batista, 2007; Junt et al., 2007; Phan
et al., 2007). The authors also confirm
that the accumulation of this antigen on
FDCs was dependent on expression of
the complement receptor (Phan et al.,
2007). In contrast, the FDC accumulation
of the small antigen turkey egg lysozyme
(TEL) occurred within 2 hr, in spite of the
less efficient acquisition of the smaller
antigen by follicular B cells. Although it is
not entirely clear at this stage whether
this antigen is in the form of immune
complexes, it is evident that smaller
antigens can be transported to FDCs in
a B cell-independent manner.
Inaneffort tocharacterize thisalternative
mechanism, the authors examined the
distribution of the PE and TEL antigens,
alongside dextran molecules of various
molecular weights, by using intravital
multiphoton microscopy. They observed
that larger molecules were found within
follicular interstitial pools in a timescale
consistentwith that ofmacrophage-medi-
ated antigen presentation (Carrasco and
Batista, 2007; Junt et al., 2007; Phan
et al., 2007). In contrast, and somewhatElsevier Inc.surprisingly, smaller dextrans and TEL
were found to rapidly fill reticular collagen
fibers originating at the SCS and pene-
trating into the follicle. Indeed, more
extensive ultrastructural analysis through
electron microscopy revealed that small
antigen colocalizedwith follicular conduits
costained with antibodies to ER-TR7,
gp38, and fibronectin. Although these
follicular conduits were not observed in
a previous investigation (Pape et al.,
2007), this discrepancy can be explained
by the different methodologies employed
by the two studies. However, although
these two studies together arrive at the
consensus that smaller antigen may
access follicular B cells in a cell-indepen-
dent manner, the relative importance of
these two alternative mechanisms is yet
to be determined. It would thus prove
extremely useful to carry out a high-reso-
lution characterization of the pores in the
SCS in a similar manner as has been per-
formed for the follicular conduits in this
current study.
The observed size-exclusion limit
suggests that these follicular conduits
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Previewsmay be similar in organization and struc-
ture to those previously observed in the
T cell zone (Gretz et al., 2000). This orig-
inal description was based on the obser-
vation that lymph-borne molecules below
approximately 70 kDa, but not larger
molecules, were localized within defined
regions of the LN cortex after subcuta-
neous administration (Gretz et al., 2000).
Closer inspection revealed that these
small molecules were contained within
fibrous networks extending from the
SCS to the high endothelial vessels in
the LN interior and predominantly local-
ized in the T cell zones. Given that these
fibers are comprised of collagen fibrils
ensheathed by fibroreticular cells (FRCs),
they contain a region of extracellular
space that can act as a ‘‘conduit’’ for
molecules below a defined hydrodynamic
radius. The functional significance of this
network in antigen transport to T lympho-
cytes was realized after characterization
of a population of dendritic cells (DCs)
associated with the conduit network
(Sixt et al., 2005). These strategically posi-
tioned DCs acquired and processed small
molecules that were transported through
the conduit network, and they thus could
present this antigen to T cells.
In view of the role of these conduits in
antigen presentation to T cells, it is impor-
tant to ask, what is the contribution of
the follicular conduits to the initiation of
B cell activation? In the current paper,
the authors suggest and investigate two
potential roles for the follicular conduits.
The first of these is the efficient delivery
of antigen to follicular B cells. In support
of this potential role, specific B cells that
had acquired antigen were often closely
associated with the conduit network.
Indeed, a number of B cells were found
to access antigen by extending pseudo-
pods into the conduits and directly
contact the collagen core. Furthermore,
only specific B cells that had engagedantigen exhibited a rapid and transient
reduction in instantaneous velocity. The
authors demonstrated that antigen deliv-
ered through the conduit system was
capable of initiating B cell activation by
the upregulation of the activation marker
CD86 and the repolarization of B cells to
the B-T cell boundary. Interestingly, the
kinetics of antigen accumulation by these
specific B cells suggests that the conduits
offer a more efficient mechanism of
antigen delivery than simple diffusion
from the SCS. Given that the follicular
conduits both structurally and functionally
resemble the conduits observed previ-
ously in the T cell zone, it will be informa-
tive in the future to establish whether any
differences exist between the two conduit
systems or whether the two comprise
a continuous network within the LN. In
addition, future work might also investi-
gate the potential for these conduits to
mediate direct delivery of small antigens
to FDCs, and it thus could clarify the role
of FDCs in the presentation of antigen to
naive B cells.
The second proposed role for the follic-
ular conduits is the transport of chemo-
kines, which allows regulation of follicular
B cell migration. In support of this sugges-
tion, the follicular conduits were found
to contain the B cell chemoattractant
CXCL13 after administration of low-
molecular-weight antigen. The authors
suggest that the follicular conduits may
act as channels to distribute CXCL13
produced at sites of inflammation.
Furthermore, and in view of higher-resolu-
tion images, they also speculate that
CXCL13 secreted by CD35 follicular
stromal cells might enter the conduit
network and mediate the recruitment of
B cells to a likely site of antigen encounter.
Though the evidence for this mechanism
is suggestive rather than conclusive, it
represents perhaps the most interesting
observation from this study and certainlyImmunity 30,warrants further investigation. Indeed,
this kind of study might help to clarify the
source of CXCL13 within the follicle, an
issue that has remained controversial for
a numberof years (AllenandCyster, 2008).
Overall, the current article by Roozen-
daal et al. (2009) contributes a third means
by which follicular B cells encounter anti-
gen and suggests an interesting mecha-
nism mediated by chemokines that may
regulate the likelihood such an encounter
(Figure 1). The variety of mechanisms that
the immune system uses to facilitate the
meeting of antigen with cognate lympho-
cytes provides an elegant illustration of
its extraordinary capacity to fine tune its
responses to a huge array of potentially
pathogenic invaders.
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